Market Overview:
The global oxacillin market is expected to register a CAGR of 5.5% during the forecast period, 2018-2030. The growth in the market can be attributed to factors such as rising incidence of hospital-acquired infections (HAIs), increasing demand for injectable drugs, and growing number of drug stores. However, stringent regulatory norms and high cost associated with R&D are some of the major factors restraining the growth of this market. Based on type, the global oxacillin market is segmented into intravenous and intramuscular segments. The intravenous segment is expected to account for a larger share in terms of revenue in 2018 owing to its higher adoption rates across hospitals globally. By application, the hospital segment dominates this market followed by drug store segments respectively owing to increase incidences HAIs across globe .
Product Definition:
Oxacillin is a penicillin antibiotic used to treat a variety of bacterial infections. It works by stopping the growth of bacteria.
Intravenous:
Intravenous is a medical procedure by which drugs and fluids are introduced into the blood vessels of the body through a tube. Intravenous drug delivery has become an integral part of modern medicine. It is one of the most common modes of administration in clinical trials as well as in-patient treatment, especially for injectable drugs.
Intramuscular:
Intramuscular is used to treat bacterial infections in the muscle tissues. It works by killing the bacteria that are found there. Intramuscular injections of antibiotics are usually used for treating mild to moderate cases of infectious diseases, such as cellulitis, furunculosis, and pyomyositis. The medicine is often administered when other forms of antibiotic treatment have failed or cannot be used because of certain medical conditions, such as renal failure or allergies to some antibiotics.
Application Insights:
The global oxacillin market is segmented by application into hospital and drug store. The hospital segment dominated the market in 2017, accounting for over 60% of the overall revenue share. This can be attributed to growing antibiotic usage in hospitals on a daily basis as well as increasing awareness about infections being passed from patient to patient due to improper hygiene measures such as not washing hands properly or not cleaning surfaces that have been occupied by patients with their mouths.
Drug stores are expected to witness significant growth during the forecast period owing to rising incidences of healthcare-associated infections which are also known as HAIs. These types of infections occur most often among hospitalized patients and elderly people who live alone at home without regular checkups or health care visits, especially if they suffer from chronic conditions or were recently diagnosed with an illness such as cancer which requires proper treatment and monitoring throughout recovery process at home.
Regional Analysis:
Asia Pacific dominated the global market in 2017 and is expected to continue its dominance over the forecast period. The presence of a large number of manufacturers coupled with increasing demand for generic drugs in this region is anticipated to drive growth. China, India, Japan, South Korea are some of the largest markets that present significant opportunities for foreign players as well as domestic ones.
The oxacillin market in Europe was valued at USD X million and is expected to grow at a CAGR of XX% from 2018 to 2030 owing to rising product consumption by patients suffering from skin infections such as cellulitis and impetigo along with respiratory tract infections caused by bacteria such as Staphylococcus Aureus or Streptococcus pneumoniae among others (Figure 1). In addition, growing geriatric population prone to various diseases will also boost revenue generation over the coming years.
Growth Factors:
- Increasing demand for oxacillin in the treatment of serious infections caused by gram-positive bacteria.
- Rising prevalence of hospital-acquired and community-acquired infections due to antibiotic resistance.
- Growing number of clinical studies that demonstrate the efficacy of oxacillin in treating various types of infections.
- increasing use of oxacillin as a prophylactic agent to prevent infection in high risk patients undergoing surgery or other invasive procedures .
Scope Of The Report
Report Attributes
Report Details
Report Title
Oxacillin Market Research Report
By Type
Intravenous, Intramuscular
By Application
Hospital, Drug Store
By Companies
Glaxosmithkline (GSK), Apothecon Pharmaceuticals, Teva Pharmaceuticals, Baxter, Watson Laboratories, Novartis, Pfizer, Bayer, Bristol-Myers Squibb, Virbac
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
155
Number of Tables & Figures
109
Customization Available
Yes, the report can be customized as per your need.
Global Oxacillin Market Report Segments:
The global Oxacillin market is segmented on the basis of:
Types
Intravenous, Intramuscular
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Drug Store
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Glaxosmithkline (GSK)
- Apothecon Pharmaceuticals
- Teva Pharmaceuticals
- Baxter
- Watson Laboratories
- Novartis
- Pfizer
- Bayer
- Bristol-Myers Squibb
- Virbac
Highlights of The Oxacillin Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Intravenous
- Intramuscular
- By Application:
- Hospital
- Drug Store
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Oxacillin Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Oxacillin is a type of antibiotic. It is used to treat infections caused by bacteria. Oxacillin can also be used to treat other types of infections, such as colds and bronchitis.
Some of the major players in the oxacillin market are Glaxosmithkline (GSK), Apothecon Pharmaceuticals, Teva Pharmaceuticals, Baxter, Watson Laboratories, Novartis, Pfizer, Bayer, Bristol-Myers Squibb, Virbac.
The oxacillin market is expected to register a CAGR of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Oxacillin Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Oxacillin Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Oxacillin Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Oxacillin Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Oxacillin Market Size & Forecast, 2018-2028
4.5.1 Oxacillin Market Size and Y-o-Y Growth
4.5.2 Oxacillin Market Absolute $ Opportunity
Chapter 5 Global Oxacillin Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Oxacillin Market Size Forecast by Type
5.2.1 Intravenous
5.2.2 Intramuscular
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Oxacillin Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Oxacillin Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Drug Store
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Oxacillin Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Oxacillin Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Oxacillin Analysis and Forecast
9.1 Introduction
9.2 North America Oxacillin Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Oxacillin Market Size Forecast by Type
9.6.1 Intravenous
9.6.2 Intramuscular
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Oxacillin Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Drug Store
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Oxacillin Analysis and Forecast
10.1 Introduction
10.2 Europe Oxacillin Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Oxacillin Market Size Forecast by Type
10.6.1 Intravenous
10.6.2 Intramuscular
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Oxacillin Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Drug Store
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Oxacillin Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Oxacillin Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Oxacillin Market Size Forecast by Type
11.6.1 Intravenous
11.6.2 Intramuscular
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Oxacillin Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Drug Store
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Oxacillin Analysis and Forecast
12.1 Introduction
12.2 Latin America Oxacillin Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Oxacillin Market Size Forecast by Type
12.6.1 Intravenous
12.6.2 Intramuscular
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Oxacillin Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Drug Store
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Oxacillin Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Oxacillin Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Oxacillin Market Size Forecast by Type
13.6.1 Intravenous
13.6.2 Intramuscular
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Oxacillin Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Drug Store
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Oxacillin Market: Competitive Dashboard
14.2 Global Oxacillin Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Glaxosmithkline (GSK)
14.3.2 Apothecon Pharmaceuticals
14.3.3 Teva Pharmaceuticals
14.3.4 Baxter
14.3.5 Watson Laboratories
14.3.6 Novartis
14.3.7 Pfizer
14.3.8 Bayer
14.3.9 Bristol-Myers Squibb
14.3.10 Virbac
